Left Ventricular Assist Device Infections and the Potential Role for Dalbavancin: A Case Report.

Authors :: Howard-Anderson J
Pouch SM
Sexton ME
Mehta AK
Smith AL
Lyon GM 3rd
Friedman-Moraco R
Source :: Open forum infectious diseases [Open Forum Infect Dis] 2019 Sep 04; Vol. 6 (9), pp. ofz235. Date of Electronic Publication: 2019 Sep 04 (Print Publication: 2019).
Publication Year :: 2019
Abstract: Left ventricular assist device infections (LVADIs) are common but challenging to treat, often requiring prolonged courses of intravenous antibiotics. Dalbavancin could have a role in treating patients with chronic LVADIs given its less frequent dosing requirements. Here, we illustrate a case in which dalbavancin was used as suppressive therapy for an LVADI for greater than 7 months.<br /> (© The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America.)

Full Text Access

Tools